درباره این اپیزود
What should healthcare providers look for before trusting a shockwave therapy device?
Host Thomas Helfrich and SoftWave CEO Thomas Rhoads explore what it really means for a medical technology to be backed by evidence. Together, they discuss how clinical trials are conducted, why FDA clearance is based on device-specific data, and why independent research should play a central role in evaluating shockwave therapy technology.
In this episode, you'll learn:
Why clinical trials are the foundation of FDA clearance
How independent research evaluates whether a device actually delivers a true shockwave
The difference between peer-reviewed clinical evidence and marketing claims
Why device-specific studies matter when comparing shockwave technologies
How ongoing research continues to expand the understanding and applications of shockwave therapy
You don't need to be a researcher to understand what good evidence looks like. At the end of the day, the goal isn't to memorize clinical studies. It's to know which questions matter when evaluating shockwave therapy so that healthcare providers can make informed decisions and give patients greater confidence in the care they receive.
Chapters
00:00 - Introduction – Does Shockwave Therapy Really Work?
01:16 - How Clinical Trials Actually Work
02:09 - Why Only Two Companies Have Done the Work
03:33 - Who Runs Softwave's Clinical Trials?
04:38 - Why Professional Sports Teams Choose Softwave
05:07 - From the NFL to Entertainment
06:27 - Why the LA Rams Became a Partner
07:00 - The Three Questions Every Buyer Should Ask
07:46 - Why Doctors Buy the Wrong Device
09:00 - Marketing Claims vs. Clinical Evidence
09:55 - Why Data Matters in the Long Run
11:01 - Closing – Data Matters
